Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caligiuri

Showing results (701-710 of 1,066) with videos related to

Pageof 107
Sort By:
Nature Communications|October 9, 2021
An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastomaBo Xu, Lei Tian, Jing Chen, et al.
Scientific Reports|October 21, 2022
Personalized risk predictor for acute cellular rejection in lung transplant using soluble CD31Alexy Tran-Dinh, Quentin Laurent, Guillaume Even, et al.
Hepatology (Baltimore, Md.)|January 27, 1999
Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liverG D LeSage, A Benedetti, S Glaser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2010
TCR stimulation drives cleavage and shedding of the ITIM receptor CD31Giulia Fornasa, Emilie Groyer, Marc Clement, et al.
Blood|October 4, 2012
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myelomaDon M Benson, Craig C Hofmeister, Swaminathan Padmanabhan, et al.
Cardiovascular Research|November 26, 2013
M1 macrophages act as LTβR-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesisKevin Guedj, Jamila Khallou-Laschet, Marc Clement, et al.
Circulation|December 1, 1998
Enhanced inflammatory response to coronary angioplasty in patients with severe unstable anginaG Liuzzo, A Buffon, L M Biasucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapyJohn C Byrd, John G Gribben, Bercedis L Peterson, et al.
British Journal of Haematology|February 3, 2009
The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemiaRosa Lapalombella, Aruna Gowda, Trupti Joshi, et al.
Cardiovascular Research|February 2, 2012
A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formationGiulia Fornasa, Marc Clement, Emilie Groyer, et al.
Pageof 107

Showing results (701-710 of 1,066) with videos related to

Sort By:
Pageof 107
Nature Communications|October 9, 2021
An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastomaBo Xu, Lei Tian, Jing Chen, et al.
Scientific Reports|October 21, 2022
Personalized risk predictor for acute cellular rejection in lung transplant using soluble CD31Alexy Tran-Dinh, Quentin Laurent, Guillaume Even, et al.
Hepatology (Baltimore, Md.)|January 27, 1999
Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liverG D LeSage, A Benedetti, S Glaser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2010
TCR stimulation drives cleavage and shedding of the ITIM receptor CD31Giulia Fornasa, Emilie Groyer, Marc Clement, et al.
Blood|October 4, 2012
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myelomaDon M Benson, Craig C Hofmeister, Swaminathan Padmanabhan, et al.
Cardiovascular Research|November 26, 2013
M1 macrophages act as LTβR-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesisKevin Guedj, Jamila Khallou-Laschet, Marc Clement, et al.
Circulation|December 1, 1998
Enhanced inflammatory response to coronary angioplasty in patients with severe unstable anginaG Liuzzo, A Buffon, L M Biasucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapyJohn C Byrd, John G Gribben, Bercedis L Peterson, et al.
British Journal of Haematology|February 3, 2009
The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemiaRosa Lapalombella, Aruna Gowda, Trupti Joshi, et al.
Cardiovascular Research|February 2, 2012
A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formationGiulia Fornasa, Marc Clement, Emilie Groyer, et al.
Pageof 107